Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine

Psychopharmacology

Volumn 130, Issue 1, 1997, Pages 41-58

  Walsh, Sharon L ^a   Cunningham, Kathryn A ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

5 HT(1A); 5 HT2; 5 HT3; Cocaine; Dopamine (DA); Drug discrimination; Human; Rat; Reinforcing effects; Reuptake inhibitor; Self administration; Serotonin (5 HT); Stimulus effects; Subjective effects

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 (4 METHYL 1 PIPERAZINYL) 7 TRIFLUOROMETHYLPYRROLO[1,2 A]QUINOXALINE; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; BUSPIRONE; CITALOPRAM; COCAINE; FLUOXETINE; FLUVOXAMINE; GEPIRONE; IMIPRAMINE; IPSAPIRONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; NEUROTOXIN; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2 AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRYPTOPHAN; UNINDEXED DRUG;

ANIMAL MODEL; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG MECHANISM; HUMAN; METHODOLOGY; MOOD; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; SEROTONINERGIC SYSTEM; SPECIES DIFFERENCE;

ANIMALS; COCAINE; DISCRIMINATION (PSYCHOLOGY); HUMANS; REINFORCEMENT (PSYCHOLOGY); SEROTONIN;

EID: 0031037946     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050210     Document Type: Review

References (136)

1. Aghajanian GK (1995) Electrophysiology of serotonin receptor subtypes and signal transduction pathways. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 451-460
2. Appel JB, White FJ, Holohean AM (1982) Analyzing mechanisms of hallucinogenic drug action with drug discrimination. Neurosci Biobehav Rev 6: 529-536
3. Aronson SC, Black JE, McDougle CJ, Scanley BE, Jatlow P, Kosten TR, Heninger GR, Price LH (1995) Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology 119: 179-185
4. 1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY 100135, but not WAY 100635, has partial agonist properties. Eur J Pharmacol 304: 15-21
5. Auerbach SB, Rutter JJ, Juliano J (1991) Substituted piperazine and indole compounds increase extracellular serotonin in rat diencephalon as determined by in vivo microdialysis. Neuropharmacology 30: 307-311
6. Baker LE, Riddle EE, Saunders RB, Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4: 69-79
7. 1A activity in the discriminative stimulus effects of imipramine. Pharmacol Biochem Behav 38: 407-410
8. Batki SL, Manfredi LB, Jacob P, Jones RT (1993) Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharmacol 13: 243-250
9. Batki SL, Washburn AM, Delucchi K, Jones RT (1996) A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend 41: 137-142
10. Berendsen HHG, Broekkamp CLE (1994) Comparison of stimulus properties of fluoxetine and 5-HT receptor agonists in a conditioned taste aversion procedure. Eur J Pharmacol 253: 83-89
11. 1 agonists. In: Harris LS (ed) Problems of drug dependence 1991. US Gov't Printing Office, Washington, D.C., pp 185-189
12. Biggio G, Fadda D, Fanni P, Tagliamonte A, Gessa GL (1974) Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. Life Sci 14: 1321-1329
13. Branchek T (1993) Receptor diversity: more serotonin receptors. Curr Biol 3: 315-317
14. 2 receptor function in rats. J Pharmacol Exp Ther 266: 585-592
15. Callahan PM, Cunningham KA (1993b) Attenuation of the interoceptive ("subjective") effects of cocaine by the novel antidepressant trazodone: possible therapeutic efficacy in cocaine abuse? In: Hams LS (ed) Problems of drug dependence 1992. National Institute on Drug Abuse Research Monograph No. 132. US Gov't Printing Office, Washington, D.C,. p 252
16. 2C receptors. J Pharmacol Exp Ther 274: 1414-1424
17. Callahan PM, Cunningham KA (1995b) Analysis of the effects of diverse antidepressants on the discriminative stimulus effects of cocaine. In: Harris LS (ed) Problems of drug dependence 1994. U S Gov't Printing Office, Washington, D.C., p 383
18. 1B receptor agonists to modulate the discriminative stimulus properties of cocaine in rats. Neuropharmacology (in press)
19. 2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology 103: 50-55
20. 1 receptors in nucleus accumbens. Psychopharmacology 115: 110-114
21. 1 receptor blockade in the amygdala. Pharmacol Biochem Behav 51: 759-766
22. Carroll ME, Lac ST, Asencio M, Kragh R (1990a) Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan. Psychopharmacology 100: 293-300
23. Carroll ME, Lac ST, Asencio M, Kragh R (1990b) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35: 237-244
24. Chadwick MJ, Gregory DL, Wendling G (1990) A double-blind amino acids, L-tryptophan and L-tyrosine, and placebo study with cocaine-dependent subjects in an inpatient chemical dependency treatment center. Am J Drug Alcohol Abuse 16: 275-286
25. Childress A, Ehrman R, McLellan A, O'Brien C (1988a) Update on behavioral treatments for substance abuse. In: Harris LS (ed) Problems of drug dependence 1987. US Gov't Printing Office, Washington, D.C., pp 183-192
26. Childress A, McLellan AT, Ehrman R, O'Brien CP (1988b) Conditioned craving and arousal in cocaine addictions: a preliminary report. In: Harris LS (ed) Problems of drug dependence 1987. US Gov't Printing Office, Washington, D.C., pp 74-80
27. 1A receptors. J Med Chem 36: 1509-1510
28. Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1C) receptors. J Pharmacol Exp Ther 242: 552-557
29. Cooper SJ, Van der Hoek GA (1993) Cocaine: a microstructural analysis of its effects on feeding and associated behaviour in the rat. Brain Res 608: 45-51
30. Covi L, Hess JM, Kreiter NA, Haertzen CA (1995) Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse 21: 327-344
31. Cunningham KA, Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104: 177-180
32. 3 antagonist zacopride on development and expression of cocaine sensitization. Soc Neurosci Abstr 23: 1850
33. 3 compounds in a drug discrimination model. Pharmacol Biochem Behav 54: 533-540
34. de Wit H, Wise RA (1977) Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol 31: 195-203
35. Delfs JM, Schreiber L, Kelley AE (1990) Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J Neurosci 10: 303-310
36. Depoortere RY, Li DH, Lane JD, Emmett-Oglesby MW (1993) Parameters of self-administration of cocaine in rats under a procressive-ratio schedule. Pharmacol Biochem Behav 45: 539-548
37. Dworkin SI, Smith JE (1988) Neurobehavioral pharmacology of cocaine. In: Clouet D, Asghar K, Brown R (eds) Mechanisms of cocaine abuse and toxicity. US Gov't Printing Office Washington, D.C., pp 185-198
38. Fallon JH, Moore RY (1978) Catecholamine innervation of basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and striatum. J Comp Neurol 180: 545-580
39. Fischman MW, Schuster CR (1982) Cocaine self-administration in humans. Fed Proc 41: 241-246
40. Fischman MW, Foltin RW, Nestadt G, Pearlson GD (1990) Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther 253: 760-770
41. 1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol Sci 14: 441-448
42. Foltin RW, Fischman MW (1991) Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257: 247-261
43. Fuxe K, Jonsson G (1974) Further mapping of central 5 HT neurons: studies with the neurotoxic dihydroxytryptamines. Adv Biochem Psychopharmacol 10: 1-12
44. Gold LH, Balster RL (1992) Effects of buspirone and gepirone on IV cocaine self-administration in rhesus monkeys. Psychopharmacology 108: 289-294
45. Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D, Kirby K (1995) Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled, double-blind trials. J Clin Psychopharmacol 15: 163-174
46. Hatsukami D, Keenan R, Carroll M, Colon E, Geiske D, Wilson B, Huber M (1990) A method for delivery of precise doses of smoked cocaine base to humans. Pharmacol Biochem Behav 36: 1-7
47. Hatsukami DK, Thompson TN, Pentel PR, Flygare BK, Carroll ME (1994) Self-administration of smoked cocaine. Exp Clin Psychopharmacol 2: 115-125
48. Higgins ST, Bickel WK, Hughes JR (1994) Influence of an alternative reinforcer on human cocaine self-administration. Life Sci 55: 179-187
49. 1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. Eur J Pharmacol 209: 249-252
50. Howell LL, Byrd LD (1995) Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther 275: 1551-1559
51. 1 recognition sites. J Recept Res 8: 59-81
52. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46: 157-204
53. 1A receptors in rat brain. Eur J Pharmacol 271: 515-523
54. Jaffe JH, Cascella NG, Kumor KM, Sherer MA (1989) Cocaine-induced cocaine craving. Psychopharmacology 97: 59-64
55. Javaid JI, Fischman MW, Schuster CR, Dekirmenjian H, Davis JM (1978) Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science 202: 227-228
56. Johanson C-E, Barrett JE (1995) The discriminative stimulus effects of cocaine in pigeons. J Pharmacol Exp Ther 267: 1-8
57. Johanson C-E, Fischman MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41: 3-52
58. Kamien JB, Woolverton WL (1990) Buspirone blocks the discriminative stimulus effects of apomophine in monkeys. Pharmacol Biochem Behav 35: 118-120
59. 2B receptor antagonist with anxiolytic-like properties. Br J Pharmacol 117: 427-434
60. 3 receptors. Academic Press, London, pp 33-57
61. 3 receptors in rat brain using radioligand binding. Nature 330: 746-748
62. 3 ligand GR65630, to rat area postrema vagus nerve and the brain of several species. Eur J Pharmacol 159: 157-164
63. Kleven MS, Woolverton WL (1993) Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys. Drug Alcohol Depend 31: 149-158
64. Kleven MS, Anthony EW, Woolverton WL (1990) Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 254: 312-317
65. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199: 649-661
66. Koetzner L, Mastropaolo J, Deutsch SI (1995) Facilitating role of m-chlorophenylbiguanide in a cocaine discrimination. Psychopharmacology 52: 815-818
67. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13: 177-184
68. Lacosta S, Roberts DCS (1993) MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine. Pharmacol Biochem Behav 44: 161-165
69. Lamb RJ, Griffiths RR (1990) Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology 102: 183-190
70. Lane JD, Pickering CL, Hooper ML, Fagan K, Tyers MB, Emmett-Oglesby MW (1992) Failure of ondansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat. Drug Alcohol Depend 30: 151-162
71. Leccese AP, Lyness WH (1984) The effects of putative 5-hydroxytryptamine receptor active agents on d-amphetamine self administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions. Brain Res 303: 153-162
72. Loh EA, Roberts DCS (1990) Break points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology 101: 262-266
73. Lucki I (1988) Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion. J Pharmacol Exp Ther 247: 1120-1127
74. Lyness WH (1983) Effect of l-tryptophan pretreatment on d-amphetamine self-administration. Subst Alcohol Actions/Misuse 4: 305-312
75. Lyness WH, Moore KE (1983) Increased self-administration of d-amphetamine by rats pretreated with metergoline. Pharmacol Biochem Behav 18: 721-724
76. Lyness WH, Friedle NM, Moore KE (1980) Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons. Pharmacol Biochem Behav 12: 937-941
77. McGregor A, Roberts DCS (1993) Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res 624: 245-252
78. McGregor A, Lacosta S, Roberts DCS (1993) L-Tryptophan decreases the breaking point under a progressive ratio schedule of intravenous cocaine reinforcement in the rat. Pharmacol Biochem Behav 44: 651-655
79. 2 antagonist, attenuates craving for cocaine by rats. Pharmacol Biochem Behav 46: 125-129
80. Meert TF, Janssen PAJ (1992) Ritanserin, a new therapeutic approach for drug abuse. Part 2: effects on cocaine. Drug Dev Res 25: 39-53
81. Meisch RA, Lemaire GA (1993) Drug self-administration. In: van Haaren F (ed) Methods in behavioral pharmacology. Elsevier, Amsterdam, pp 257-300
82. Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14: 375-424
83. Nader MA, Barrett JE (1990) Effects of chlordiazepoxide, buspirone, and serotonin receptor agonists and antagonists on responses of squirrel monkeys maintained under second-order schedules of intramuscular cocaine injection or food presentation. Drug Dev Res 20: 5-17
84. 1C receptor mediation. Psychopharmacology 99: 196-201
85. O'Brien CP, Childress A, McLellan AT, Ehrman R, Ternes JW (1988) Progress in understanding the conditioning aspects of drug dependence. In: Harris LS (ed) Problems of drug dependence 1987. US Govt Printing Office, Washington, D.C., pp 44-61
86. 1 agonist Ru 24969 and effects on dopaminergic behavior. Eur J Pharmacol 139: 205-214
87. Oliveto AH, Rosen MI, Woods SW, Kosten TR (1995) Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans. J Pharmacol Exp Ther 272: 231-241
88. 3 antagonists do not alter the discriminative stimulus properties of cocaine. Psychopharmacology 104: 475-478
89. 3 antagonist, fails to alter cocaine self-administration in rats. Pharmacol Biochem Behav 39: 133-136
90. Peltier R, Schenk S (1993) Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology 110: 390-394
91. Peltier RL, Emmett-Oglesby MW, Thomas WH, Schenk S (1994) Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine. Pharmacol Biochem Behav 48: 473-478
92. Perez-Reyes M, Di Guiseppi S, Ondrusek G, Jeffcoat AR, Cook CE (1982) Free-base cocaine smoking. Clin Pharmacol Ther 32: 459-465
93. Perry KW, Fuller RW (1992) Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci 50: 1683-1690
94. Petrakis I, Carroll K, Gordon L, Cushing AG, Rounsaville BJ (1994) Fluoxetine treatment for dually diagnosed methadone-maintained opioid addicts: a pilot study. J Addic Dis 13: 25-32
95. Pickens RW, Johanson C-E (1992) Craving: consensus of status and agenda for future research. Drug Alcohol Depend 30: 127-131
96. 2C receptors. Mol Brain Res 23: 163-178
97. Porrino LJ, Ritz MC, Goodman NL, Sharpe LG, Kuhar MJ, Goldberg SR (1989) Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. Life Sci 45: 1529-1535
98. Post RM (1975) Cocaine psychoses: a continuum model. Am J Psychiatry 132: 225-230
99. Prisco S, Pagannone S, Esposito E (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J Pharmacol Exp Ther 271: 83-90
100. 3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur J Pharmacol 186: 327-330
101. 1B receptor activation mimics behavioral effects of presynaptic serotonin release. Neuropsychopharmacology 8: 201-211
102. Resnick R, Kestenbaum RS, Schwartz LK (1976) Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes. Science 195: 696-699
103. Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316: 126-131
104. Richardson NR, Roberts DCS (1991) Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci 49: 833-840
105. Ritchie JM, Greengard P (1966) On the mode of action of local anesthetics. Annu Rev Pharmacol 6: 405-430
106. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223
107. Roberts DCS, Loh EA, Baker GB, Vickers G (1994) Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food. Pharmacol Biochem Behav 49: 177-182
108. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11: 157-198
109. Rowbotham MC, Jones RT, Benowitz NL, Jacob P (1984) Trazodone-oral cocaine interactions. Arch Gen Psychiatry 41: 895-899
110. Rutter JJ, Gundlah C, Auerbach SB (1995) Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse 20: 225-233
111. Satel SL, Krystal JH, Delgado PL, Kosten TR, Charney DS (1995) Tryptophan depletion and attenuation of cue-induced craving for cocaine. Am J Psychiatry 152: 778-783
112. Saudou F, Hen R (1994) 5-HT receptor subtypes: molecular and functional diversity. Med Chem Res 4: 16-84
113. Schechter MD (1993) Cocaine discrimination is attenuated by isradipine and CGS 10746B. Pharmacol Biochem Behav 44: 661-664
114. Scheel-Kruger J, Braestrup C, Nielson M, Golembiowska K, Mogilnicka E (1976) Cocaine: discussion on the role of dopamine in the biochemical mechanism of action. In: Ellinwood EH, Kilbey MM (eds) Cocaine and other stimulants. Plenum Press, New York, pp 373-407
115. Schuster CR, Johanson C-E (1988) Relationship between the discriminative stimulus properties and subjective effects of drugs. Psychopharmacology 4: 161-175
116. Sharkey J, Glen KA, Wolfe S, Kuhar MJ (1988a) Cocaine binding at sigma receptors. Eur J Pharmacol 149: 171-174
117. Sharkey J, Ritz MC, Sehenden JA, Hanson RC, Kuhar MJ (1988b) Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther 246: 1048-1052
118. Simansky K, Eberle-Wang K, Geary N (1993) Serotonergic mechanisms and ingestion: pharmacological facts and physiological promises. Appetite 21: 220
119. Smith FL, Yu DSL, Smith DG, Leccese AP, Lyness WH (1986) Dietary tryptophan supplements attenuate amphetamine self-administration in the rat. Pharmacol Biochem Behav 25: 849-855
120. Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 112: 93-99
121. Spealman RD, Bergman J, Madras BK, Melia KF (1991) Discriminative stimulus effects of cocaine in squirrel monkeys: Involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 258: 945-953
122. Sullivan JT, Jasinski DR, Preston KL, Testa M, Bell JM (1992) Cocaine blocking effects of ondansetron. In: Harris LS (ed) Problems on drug dependence 1991. US Govt Printing Office, Washington, D.C., p 466
123. Sullivan JT, Testa MP, Preston KL, Blum P, Jasinski DR (1994) Psychoactivity of ritanserin and its interaction with intravenous cocaine. In: Harris LS (ed) Problems of drug dependence 1993. US Govt Printing Office, Washington, D.C., p 377
124. 3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism. Pharmacol Biochem Behav 43: 871-879
125. Tella SR (1995) Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol Biochem Behav 51: 687-692
126. Terry P, Witkin JM, Katz JL (1994) Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 270: 1041-1048
127. Ukai M, Mori E, Kameyama T (1993) Discriminative stimulus properties of cocaine in the rat using a two-choice discrete-trial avoidance paradigm. Pharmacol Biochem Behav 44: 907-911
128. 3 antagonist, reduces cocaine's psychomotor stimulated effects in the rat. Psychopharmacology 101: S59
129. Van Dyke C, Jatlow P, Ungerer P, Barash PG, Byck R (1978) Oral cocaine: plasma concentrations and central effects. Science 200: 211-213
130. Van Wijngaarden I, Tulp MTM, Soudijn W (1990) The concept of selectivity in 5-HT receptor research. Eur J Pharmacol 188: 301-312
131. Vertes RP (1991) A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 313: 643-668
132. Walsh SL, Preston KL, Sullivan JT, Fromme R, Bigelow GE (1994) Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharmacol 14: 396-407
133. Walsh SL, Sullivan JT Fromme R, Bigelow GE (1995) Fluoxetine effects on cocaine response: a double-blind laboratory assessment in humans. In: Harris LS (ed) Problems of drug dependence 1994. US Govt Printing Office, Washington, D.C., p 310
134. Witkin JM, Nichols DE, Terry P, Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257: 706-713
135. Wood DM, Emmett-Oglesby MW (1989) Mediation in the nucleus accumbens of the discriminative stimulus produced by cocaine. Pharmacol Biochem Behav 33: 453-457
136. Young SN, Smith SE, Pihl RO, Ervin FR (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87: 173-177